HELP News

Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development

Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026

Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors

Helus Pharma to Host Investor Presentation on October 21, 2026

Helus Pharma Announces Completion of Legal Name Change

Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change

Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit

Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York